Yes, factor replacement therapy can be used during pregnancy and childbirth to manage bleeding risks. Pregnant women with clotting disorders are closely monitored, and the therapy is tailored to ensure both maternal and fetal safety. Regular consultations with a hematologist and a gynecologist are essential for optimal management.
